1989Medical MycologyRequires access

Genetic and physiological analysis of azole sensitivity inSaccharomyces cerevisiae

S. Kenna, H. F. J. Bligh, P. F. Watson, Steven L. Kelly

Open publisher page 32 citations

Abstract

Ketoconazole and fluconazole are azole antifungal agents which inhibit cytochrome P-450 mediated sterol C14 demethylation during ergosterol biosynthesis. We report on the activity of these antifungals on a variety of Saccharomyces cerevisiae strains grown under differing conditions known to affect cyt P-450 levels. Only slight increases in resistance to azoles were observed under conditions which induce the yeast cyt P-450 from undetectable levels. Strain variation was observed, with some strains exhibiting a fungicidal, and others a fungistatic response. Two cyt P-450 deficient mutants examined exhibited resistance to treatment with fluconazole and ketoconazole. This was attributed, at least in part, to an additional defect in sterol delta 5,6 desaturation and possibly to reduced cellular levels of azole drug.

About this research paper

What this paper is about

Ketoconazole and fluconazole are azole antifungal agents which inhibit cytochrome P-450 mediated sterol C14 demethylation during ergosterol biosynthesis. We report on the activity of these antifungals on a variety of Saccharomyces cerevisiae strains grown under differing conditions known to affect cyt P-450 levels. Only slight increases in resistance to azoles were observed under conditions which induce the yeast cyt P-450 from undetectable levels. Strain variation was observed, with some strains exhibiting a fungicidal, and others a fungistatic response. Two cyt P-450 deficient mutants examined exhibited resistance to treatment with fluconazole and ketoconazole. This was attributed, at least in part, to an additional defect in sterol delta 5,6 desaturation and possibly to reduced cellular levels of azole drug.

Why it matters

OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ketoconazole and fluconazole are azole antifungal agents which inhibit cytochrome P-450 mediated sterol C14 demethylation during ergosterol biosynthesis. We report on the activity of these antifungals on a variety of Saccharomyces cerevisiae strains grown under differing conditions known to affect cyt P-450 levels. Only slight increases in resistance to azoles were observed under conditions which induce the yeast cyt P-450 from undetectable levels. Strain variation was observed, with some strains exhibiting a fungicidal, and others a fungistatic response. Two cyt P-450 deficient mutants examined exhibited resistance to treatment with fluconazole and ketoconazole. This was attributed, at least in part, to an additional defect in sterol delta 5,6 desaturation and possibly to reduced cellular levels of azole drug.

Key concepts: Saccharomyces cerevisiae, Azole, Sensitivity (control systems), Biology, Genetics, Computational biology, Microbiology, Gene

Related papers

Back to paper searchBrowse research topicsOriginal source
Genetic and physiological analysis of azole sensitivity inSaccharomyces cerevisiae — Research Paper | ScholarLens